The status of epidermal growth factor receptor in borderline ovarian tumours

File(s)

7257-126922-1-PB.pdf (2.64 MB)

Published version

Show more

Author(s)

Showeil, R

Romano, C

Valganon, M

Lambros, M

Trivedi, P

more

Type

Journal Article

Date Issued

2016-02-08

Date Acceptance

2016-01-23

Citation

Oncotarget, 2016, 7 (9), pp.10568-10577

URI

http://hdl.handle.net/10044/1/38516

DOI

https://www.dx.doi.org/10.18632/oncotarget.7257

ISSN

1949-2553

Publisher

Impact Journals

Start Page

10568

End Page

10577

Journal / Book Title

Oncotarget

Volume

7

Issue

9

Copyright Statement

This paper is licensed under a Creative Commons Attribution 3.0 License.

License URL

http://creativecommons.org/licenses/by/4.0/

Sponsor

Poole Hospital NHS Foundation Trust

Grant Number

N/A

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

Cell Biology

EGFR

borderline ovarian tumours

IN-SITU HYBRIDIZATION

SEROUS CARCINOMA

EGFR EXPRESSION

PROGNOSTIC VALUE

CANCER PATIENTS

BRAF MUTATIONS

BREAST-CANCER

NUCLEAR EGFR

KRAS

IMMUNOHISTOCHEMISTRY

Publication Status

Published